J. Braess et al., MUCOCUTANEOUS AUTOIMMUNE SYNDROME FOLLOWING FLUDARABINE THERAPY FOR LOW-GRADE NON-HODGKINS-LYMPHOMA OF B-CELL TYPE (B-NHL), Annals of hematology, 75(5-6), 1997, pp. 227-230
A 40-year-old patient with low-grade B-NHL developed a generalized mac
ular-papular rash following the first cycle of fludarabine treatment w
hich progressed to a complete epidermal necrolysis following the secon
d cycle. Clinical symptoms and the results of the direct and indirect
immunofluorescence were consistent with a mucocutaneous autoimmune syn
drome (pemphigus). Immunohistochemical analysis demonstrated a dense e
pidermal infiltration of CD8+ lymphocytes associated with the histolog
ical features of single-cell necrosis of keratinocytes. Early and aggr
essive immunosuppressive treatment with steroids, cyclophosphamide, an
d high-dose immunoglobulins resulted in regression of symptoms and com
plete reconstitution of epidermal integrity. The malignant lymphoma ha
s completely regressed. The findings suggest a fludarabine-induced def
ect in immunosurveillance - resulting in the uncontrolled activation o
f autoaggressive T-cell clones - as a pathogenetic mechanism of this l
ife-threatening dermatological complication.